Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 226

1.

Beta3-adrenoreceptor stimulation ameliorates myocardial ischemia-reperfusion injury via endothelial nitric oxide synthase and neuronal nitric oxide synthase activation.

Aragón JP, Condit ME, Bhushan S, Predmore BL, Patel SS, Grinsfelder DB, Gundewar S, Jha S, Calvert JW, Barouch LA, Lavu M, Wright HM, Lefer DJ.

J Am Coll Cardiol. 2011 Dec 13;58(25):2683-91. doi: 10.1016/j.jacc.2011.09.033.

2.

Nebivolol protects against myocardial infarction injury via stimulation of beta 3-adrenergic receptors and nitric oxide signaling.

Zhang Z, Ding L, Jin Z, Gao G, Li H, Zhang L, Zhang L, Lu X, Hu L, Lu B, Yu X, Hu T.

PLoS One. 2014 May 21;9(5):e98179. doi: 10.1371/journal.pone.0098179. eCollection 2014.

3.

β3-Adrenoreceptor stimulation protects against myocardial infarction injury via eNOS and nNOS activation.

Niu X, Zhao L, Li X, Xue Y, Wang B, Lv Z, Chen J, Sun D, Zheng Q.

PLoS One. 2014 Jun 9;9(6):e98713. doi: 10.1371/journal.pone.0098713. eCollection 2014.

4.

Beta3-adrenoceptor activation just says NO to myocardial reperfusion injury.

Heusch G.

J Am Coll Cardiol. 2011 Dec 13;58(25):2692-4. doi: 10.1016/j.jacc.2011.09.034. No abstract available.

5.

Selective β2-adrenoreceptor stimulation attenuates myocardial cell death and preserves cardiac function after ischemia-reperfusion injury.

Bhushan S, Kondo K, Predmore BL, Zlatopolsky M, King AL, Pearce C, Huang H, Tao YX, Condit ME, Lefer DJ.

Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1865-74. doi: 10.1161/ATVBAHA.112.251769. Epub 2012 May 31.

6.

Stimulation of platelet nitric oxide production by nebivolol prevents thrombosis.

Momi S, Caracchini R, Falcinelli E, Evangelista S, Gresele P.

Arterioscler Thromb Vasc Biol. 2014 Apr;34(4):820-9. doi: 10.1161/ATVBAHA.114.303290. Epub 2014 Feb 20.

7.

Mechanisms underlying nebivolol-induced endothelial nitric oxide synthase activation in human umbilical vein endothelial cells.

Ladage D, Brixius K, Hoyer H, Steingen C, Wesseling A, Malan D, Bloch W, Schwinger RH.

Clin Exp Pharmacol Physiol. 2006 Aug;33(8):720-4.

PMID:
16895546
8.

Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol.

Dessy C, Saliez J, Ghisdal P, Daneau G, Lobysheva II, Frérart F, Belge C, Jnaoui K, Noirhomme P, Feron O, Balligand JL.

Circulation. 2005 Aug 23;112(8):1198-205.

9.

Anti-hypertrophic and anti-oxidant effect of beta3-adrenergic stimulation in myocytes requires differential neuronal NOS phosphorylation.

Watts VL, Sepulveda FM, Cingolani OH, Ho AS, Niu X, Kim R, Miller KL, Vandegaer K, Bedja D, Gabrielson KL, Rameau G, O'Rourke B, Kass DA, Barouch LA.

J Mol Cell Cardiol. 2013 Sep;62:8-17. doi: 10.1016/j.yjmcc.2013.04.025. Epub 2013 May 2.

10.

Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation.

Maffei A, Di Pardo A, Carangi R, Carullo P, Poulet R, Gentile MT, Vecchione C, Lembo G.

Hypertension. 2007 Oct;50(4):652-6. Epub 2007 Jul 30.

11.

Regulation of endothelial nitric-oxide synthase (NOS) S-glutathionylation by neuronal NOS: evidence of a functional interaction between myocardial constitutive NOS isoforms.

Idigo WO, Reilly S, Zhang MH, Zhang YH, Jayaram R, Carnicer R, Crabtree MJ, Balligand JL, Casadei B.

J Biol Chem. 2012 Dec 21;287(52):43665-73. doi: 10.1074/jbc.M112.412031. Epub 2012 Oct 22.

12.

ENOS is not activated by nebivolol in human failing myocardium.

Brixius K, Song Q, Malick A, Boelck B, Addicks K, Bloch W, Mehlhorn U, Schwinger RH.

Life Sci. 2006 Aug 22;79(13):1234-41. Epub 2006 Apr 25.

PMID:
16716362
13.

Exercise protects against myocardial ischemia-reperfusion injury via stimulation of β(3)-adrenergic receptors and increased nitric oxide signaling: role of nitrite and nitrosothiols.

Calvert JW, Condit ME, Aragón JP, Nicholson CK, Moody BF, Hood RL, Sindler AL, Gundewar S, Seals DR, Barouch LA, Lefer DJ.

Circ Res. 2011 Jun 10;108(12):1448-58. doi: 10.1161/CIRCRESAHA.111.241117. Epub 2011 Apr 28.

14.

Nebivolol regulates eNOS and iNOS expressions and alleviates oxidative stress in cerebral ischemia/reperfusion injury in rats.

Heeba GH, El-Hanafy AA.

Life Sci. 2012 Mar 10;90(11-12):388-95. doi: 10.1016/j.lfs.2011.12.001. Epub 2011 Dec 23.

PMID:
22226906
15.

Treatment with a highly selective β₁ antagonist causes dose-dependent impairment of cerebral perfusion after hemodilution in rats.

Hu T, Beattie WS, Mazer CD, Leong-Poi H, Fujii H, Wilson DF, Tsui AK, Liu E, Muhammad M, Baker AJ, Hare GM.

Anesth Analg. 2013 Mar;116(3):649-62. doi: 10.1213/ANE.0b013e318280e26d. Epub 2013 Feb 11.

PMID:
23400988
16.

Effect of DL-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells.

Evangelista S, Garbin U, Pasini AF, Stranieri C, Boccioletti V, Cominacini L.

Pharmacol Res. 2007 Apr;55(4):303-9. Epub 2007 Jan 12.

PMID:
17280840
17.

Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury.

Jones SP, Greer JJ, Kakkar AK, Ware PD, Turnage RH, Hicks M, van Haperen R, de Crom R, Kawashima S, Yokoyama M, Lefer DJ.

Am J Physiol Heart Circ Physiol. 2004 Jan;286(1):H276-82. Epub 2003 Sep 11.

18.

Cardioprotective effect of beta-3 adrenergic receptor agonism: role of neuronal nitric oxide synthase.

Niu X, Watts VL, Cingolani OH, Sivakumaran V, Leyton-Mange JS, Ellis CL, Miller KL, Vandegaer K, Bedja D, Gabrielson KL, Paolocci N, Kass DA, Barouch LA.

J Am Coll Cardiol. 2012 May 29;59(22):1979-87. doi: 10.1016/j.jacc.2011.12.046. Erratum in: J Am Coll Cardiol. 2012 Jul 31;60(5):481.

20.

Nebivolol induces eNOS activation and NO-liberation in murine corpus cavernosum.

Reidenbach C, Schwinger RH, Steinritz D, Kehe K, Thiermann H, Klotz T, Sommer F, Bloch W, Brixius K.

Life Sci. 2007 Jun 6;80(26):2421-7. Epub 2007 Apr 25.

PMID:
17512554

Supplemental Content

Support Center